Gaofeng Shu
Gaofeng Shu has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Jiansong Ji
Department of Radiology, Lishui Hospital of Zhejiang University, Lishui, China
4 shared publications Jiayi Ding
Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research The Fifth Affiliated Hospital of Wenzhou Medical University Lishui China
3 shared publications- Minjiang Chen
Department of Pulmonary and Critical Care Medicine Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China
3 shared publications - Zhongwei Zhao
Medical College, Yanbian University, Yanji, People’s Republic of China
3 shared publications Enqi Qiao
Department of radiology, Lishui Hospital of Zhejiang University, School of Medicine, Lishui 323000, China
2 shared publicationsJunchao Yu
Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, Institute of Imaging Diagnosis and Minimally Invasive Intervention Research, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, China
2 shared publications
Latest Publications
- Open Access
- 1 February 2023
- Published by Wiley in The FASEB Journal
- Vol. 37 (3) , e22791
The role of metabolic reprogramming of oxygen‐induced macrophages in the dynamic changes of atherosclerotic plaques
Atherosclerosis (As) is a chronic vascular inflammatory disease. Macrophages are the most important immune cells in atherosclerotic plaques, and the phenotype of plaque macrophages shifts dynamically to adapt to changes in the plaque microenvironment. The aerobic microenvironment of early atherosclerotic plaques promotes the transformation of M2/alternatively activated macrophages mainly through oxidative phosphorylation; the anoxic microenvironment of advanced atherosclerotic plaques mainly promotes the formation of M1/classically activated macrophages through anaerobic glycolysis; and the adventitia angiogenesis of aged atherosclerotic plaques leads to an increase in the proportion of M2/M1 macrophages. Therefore, this review deeply elucidates the dynamic change mechanism of plaque macrophages and the regulation of plaque oxygen content and immune metabolism to find new targets for the treatment of As.
- 1 February 2023
- Published by Wiley in The FASEB Journal
- Vol. 37 (3) , e22791
Open AccessThe role of metabolic reprogramming of oxygen‐induced macrophages in the dynamic changes of atherosclerotic plaques
Atherosclerosis (As) is a chronic vascular inflammatory disease. Macrophages are the most important immune cells in atherosclerotic plaques, and the phenotype of plaque macrophages shifts dynamically to adapt to changes in the plaque microenvironment. The aerobic microenvironment of early atherosclerotic plaques promotes the transformation of M2/alternatively activated macrophages mainly through oxidative phosphorylation; the anoxic microenvironment of advanced atherosclerotic plaques mainly promotes the formation of M1/classically activated macrophages through anaerobic glycolysis; and the adventitia angiogenesis of aged atherosclerotic plaques leads to an increase in the proportion of M2/M1 macrophages. Therefore, this review deeply elucidates the dynamic change mechanism of plaque macrophages and the regulation of plaque oxygen content and immune metabolism to find new targets for the treatment of As.
- 4 January 2023
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 231, 123160
Monodisperse CaCO3-loaded gelatin microspheres for reversing lactic acid-induced chemotherapy resistance during TACE treatment
- 4 January 2023
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 231, 123160
Monodisperse CaCO3-loaded gelatin microspheres for reversing lactic acid-induced chemotherapy resistance during TACE treatment
- Open Access
- 14 October 2022
- Published by Elsevier in Asian Journal of Pharmaceutical Sciences
- Vol. 17 (6) , 908-923
Fucoidan-based dual-targeting mesoporous polydopamine for enhanced MRI-guided chemo-photothermal therapy of HCC via P-selectin-mediated drug delivery
- 14 October 2022
- Published by Elsevier in Asian Journal of Pharmaceutical Sciences
- Vol. 17 (6) , 908-923
Open AccessFucoidan-based dual-targeting mesoporous polydopamine for enhanced MRI-guided chemo-photothermal therapy of HCC via P-selectin-mediated drug delivery
- 22 February 2022
- Published by Elsevier in Pharmacological Research
- Vol. 177, 106140
Piperlongumine synergistically enhances the antitumour activity of sorafenib by mediating ROS-AMPK activation and targeting CPSF7 in liver cancer
- 22 February 2022
- Published by Elsevier in Pharmacological Research
- Vol. 177, 106140
Piperlongumine synergistically enhances the antitumour activity of sorafenib by mediating ROS-AMPK activation and targeting CPSF7 in liver cancer
- Top Cited PapersOpen Access
- 9 October 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (41) , eabb7422
ROS-responsive chitosan-SS31 prodrug for AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule
An SS31 prodrug improved AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule.
- 9 October 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (41) , eabb7422
Top Cited PapersOpen AccessROS-responsive chitosan-SS31 prodrug for AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule
An SS31 prodrug improved AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule.